In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer.
breast murine tumor lines
fatty acid uptake
fluorescence microscopy
metabolism
metastatic potential
oncogene addition
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
05 Jan 2021
05 Jan 2021
Historique:
received:
02
11
2020
revised:
23
12
2020
accepted:
31
12
2020
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
21
1
2021
Statut:
epublish
Résumé
Targeting a tumor's metabolic dependencies is a clinically actionable therapeutic approach; however, identifying subtypes of tumors likely to respond remains difficult. The use of lipids as a nutrient source is of particular importance, especially in breast cancer. Imaging techniques offer the opportunity to quantify nutrient use in preclinical tumor models to guide development of new drugs that restrict uptake or utilization of these nutrients. We describe a fast and dynamic approach to image fatty acid uptake in vivo and demonstrate its relevance to study both tumor metabolic reprogramming directly, as well as the effectiveness of drugs targeting lipid metabolism. Specifically, we developed a quantitative optical approach to spatially and longitudinally map the kinetics of long-chain fatty acid uptake in in vivo murine models of breast cancer using a fluorescently labeled palmitate molecule, Bodipy FL c16. We chose intra-vital microscopy of mammary tumor windows to validate our approach in two orthotopic breast cancer models: a MYC-overexpressing, transgenic, triple-negative breast cancer (TNBC) model and a murine model of the 4T1 family. Following injection, Bodipy FL c16 fluorescence increased and reached its maximum after approximately 30 min, with the signal remaining stable during the 30-80 min post-injection period. We used the fluorescence at 60 min (Bodipy
Identifiants
pubmed: 33466329
pii: cancers13010148
doi: 10.3390/cancers13010148
pmc: PMC7794847
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIH HHS
ID : F31CA243194
Pays : United States
Organisme : NIH HHS
ID : T32-EB001040
Pays : United States
Organisme : NCI NIH HHS
ID : F31 CA243468
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB028148
Pays : United States
Organisme : NIH HHS
ID : R01EB028148
Pays : United States
Organisme : NIH HHS
ID : F32CA243548
Pays : United States
Organisme : NIH HHS
ID : F31CA243468
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA223817
Pays : United States
Organisme : Congressionally Directed Medical Research Programs
ID : W81XWH-16-1-0603
Organisme : NIH HHS
ID : R01CA223817
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA243548
Pays : United States
Organisme : Congressionally Directed Medical Research Programs
ID : W81XWH-18-1-0713
Références
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Metab. 2018 Nov 15;6:14
pubmed: 30473788
Nat Med. 2011 Oct 30;17(11):1498-503
pubmed: 22037646
Anticancer Res. 2016 Sep;36(9):4655-60
pubmed: 27630308
Sci Rep. 2014 May 13;4:4927
pubmed: 24820099
Nat Med. 2016 Apr;22(4):427-32
pubmed: 26950360
Clin Cancer Res. 2009 Nov 1;15(21):6479-83
pubmed: 19861459
Nat Immunol. 2020 Nov;21(11):1444-1455
pubmed: 32958928
Acad Radiol. 2006 Jun;13(6):713-20
pubmed: 16679273
J Cell Biol. 1991 Jun;113(6):1267-79
pubmed: 2045412
Cell Rep. 2016 Mar 8;14(9):2154-2165
pubmed: 26923594
J Biol Chem. 2008 Jan 18;283(3):1391-400
pubmed: 17991742
Cancer Res. 2015 Apr 15;75(8):1567-79
pubmed: 25878146
Breast Cancer Res. 2000;2(5):331-4
pubmed: 11250725
Med Princ Pract. 2011;20(5):397-415
pubmed: 21757928
Insights Imaging. 2012 Dec;3(6):573-89
pubmed: 23093486
Biotechniques. 2011 Feb;50(2):98-115
pubmed: 21486251
Sci Transl Med. 2019 Feb 6;11(478):
pubmed: 30728288
Cell Rep. 2019 Dec 10;29(11):3405-3420.e5
pubmed: 31825825
Cancer Res. 2014 Sep 15;74(18):5184-94
pubmed: 25100563
Br J Cancer. 2020 Mar;122(6):868-884
pubmed: 31942031
Cancer Res. 2019 May 1;79(9):2136-2151
pubmed: 30862716
Sci Rep. 2017 Oct 23;7(1):13772
pubmed: 29062013
PLoS One. 2014 Apr 10;9(4):e94017
pubmed: 24722644
Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):412-26
pubmed: 10634967
Genome Biol. 2014;15(12):550
pubmed: 25516281
Methods Mol Biol. 2012;872:31-50
pubmed: 22700402
Mitochondrion. 2009 Nov;9(6):429-37
pubmed: 19671450
Front Cell Dev Biol. 2017 Apr 11;5:35
pubmed: 28443280
Oncogenesis. 2016 Jan 25;5:e189
pubmed: 26807644
Biochim Biophys Acta. 2012 Sep;1822(9):1411-20
pubmed: 22366061
PLoS One. 2014 Dec 19;9(12):e115529
pubmed: 25526261
Medchemcomm. 2016 Apr 1;7(4):612-622
pubmed: 27446528
Cancer Res. 2013 Oct 15;73(20):6164-74
pubmed: 24130112
PLoS One. 2013 Oct 18;8(10):e76524
pubmed: 24204635
Science. 2020 Apr 10;368(6487):
pubmed: 32273439
Sci Rep. 2018 Mar 8;8(1):4171
pubmed: 29520098
Cancers (Basel). 2015 Jan 15;7(1):143-78
pubmed: 25599228
J Biol Chem. 2010 Mar 26;285(13):9317-21
pubmed: 20139083
Breast. 2015 Nov;24 Suppl 2:S36-40
pubmed: 26253813
J Biol Chem. 2019 Feb 15;294(7):2302-2317
pubmed: 30559289
Cell Rep. 2020 Mar 10;30(10):3368-3382.e7
pubmed: 32160543
Oncol Lett. 2011 May;2(3):525-530
pubmed: 22866115
Mol Cell Oncol. 2020 Jan 23;7(2):1715766
pubmed: 32158927
PLoS One. 2013 May 31;8(5):e64561
pubmed: 23741339
J Hematol Oncol. 2019 Sep 10;12(1):95
pubmed: 31500658
Curr Opin Lipidol. 2007 Feb;18(1):66-71
pubmed: 17218835
Int J Cancer. 2013 Apr 1;132(7):1613-23
pubmed: 22965462
Sci Rep. 2016 Feb 11;6:20984
pubmed: 26865432
Analyst. 2015 Apr 7;140(7):2224-35
pubmed: 25730442
Clin Cancer Res. 2005 Apr 15;11(8):2785-808
pubmed: 15837727
Nat Med. 2001 Feb;7(2):235-9
pubmed: 11175856
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19494-9
pubmed: 18042710
Nat Methods. 2018 Jan;15(1):73-80
pubmed: 29176592
PLoS One. 2014 Mar 04;9(3):e90746
pubmed: 24595244
Mol Cell Biochem. 2007 May;299(1-2):67-73
pubmed: 16645726
Mol Aspects Med. 2013 Apr-Jun;34(2-3):516-28
pubmed: 23506886
Neoplasia. 2009 Mar;11(3):247-59, 2p following 259
pubmed: 19242606
J Exp Med. 2012 Apr 9;209(4):679-96
pubmed: 22430491
Nat Cell Biol. 2019 Sep;21(9):1113-1126
pubmed: 31451770
Cancer Discov. 2012 Oct;2(10):881-98
pubmed: 23009760
Intravital. 2014 Aug 11;3(2):e29917
pubmed: 28243510
J Lipid Res. 2010 Sep;51(9):2761-5
pubmed: 20526002
Cancer Res. 2011 Apr 1;71(7):2455-65
pubmed: 21459803
Cell. 2015 Jan 29;160(3):477-88
pubmed: 25619689
Int J Mol Sci. 2019 Nov 11;20(22):
pubmed: 31717935
Methods Mol Biol. 2011;693:103-15
pubmed: 21080277
Nature. 2019 Nov;575(7782):380-384
pubmed: 31666695
Magn Reson Imaging. 2017 Nov;43:105-109
pubmed: 28716678
Sci Rep. 2018 May 8;8(1):7226
pubmed: 29740111
Mol Cancer Res. 2019 Jul;17(7):1545-1555
pubmed: 30902832
Cancer Biol Med. 2014 Mar;11(1):1-19
pubmed: 24738035
Sci Rep. 2020 Feb 26;10(1):3490
pubmed: 32103057
Cell Metab. 2016 Aug 9;24(2):311-23
pubmed: 27508876
Sci Rep. 2020 Mar 9;10(1):4363
pubmed: 32152409
Cells. 2019 Aug 08;8(8):
pubmed: 31398937
Immunity. 2014 Jul 17;41(1):75-88
pubmed: 25001241
Mol Imaging Biol. 2019 Feb;21(1):1-10
pubmed: 29516387
Neoplasia. 2019 Jun;21(6):615-626
pubmed: 31078067
Oncogene. 2009 Jul 30;28(30):2745-55
pubmed: 19483720
J Clin Invest. 2017 Jun 1;127(6):2091-2105
pubmed: 28504653
Cell Syst. 2018 Mar 28;6(3):282-300.e2
pubmed: 29596783
Sci Rep. 2016 Jan 04;6:18669
pubmed: 26725848
Immunol Endocr Metab Agents Med Chem. 2009 Sep;9(1):11-17
pubmed: 26635907
Cell Rep. 2015 Mar 17;10(10):1681-1691
pubmed: 25772356
Neoplasia. 2015 Aug;17(8):671-84
pubmed: 26408259
J Lipid Res. 2008 Jan;49(1):230-44
pubmed: 17928635
Cancer Res. 1992 Mar 15;52(6):1399-405
pubmed: 1540948
Cancer Res. 2008 Oct 15;68(20):8607-15
pubmed: 18922937
Int J Dev Biol. 2011;55(7-9):851-9
pubmed: 21948738
J Nucl Med. 1991 Oct;32(10):1888-96
pubmed: 1919727
Front Oncol. 2017 Jan 31;7:3
pubmed: 28197395
World J Diabetes. 2010 Jul 15;1(3):76-88
pubmed: 21537431
Sci Rep. 2018 May 29;8(1):8267
pubmed: 29844613